drugset
drugset / Press release

AlgiPharma granted Orphan Drug designation by FDA

2016-02-24 · AlgiPharma AS · original algipharma.com ↗

OligoG · regulatory

AlgiPharma was granted Orphan Drug designation by the FDA for its sodium alginate oligosaccharide, OligoG in the treatment of cystic fibrosis (CF). Yngvar P. Berg, CEO; [email protected] February 24, 2016

The release as fetched from its publisher. algipharma.com ↗